BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ApaTech Ltd Wins Deloitte Technology Fast 50 Award


10/28/2009 11:49:53 AM

UK -- ApaTech®, the rapidly growing orthobiologics company, has won the bronze award in the Deloitte Technology Fast 50 as a result of its outstanding five year sales growth rate of 8,318 per cent.

This award is yet another significant accolade to add to ApaTech’s recent successes. In September 2009 ApaTech came second in the Sunday Times Fast Track and remained Britain’s fastest growing medical technology company for the third successive year. This award sits alongside the Frost & Sullivan award as N American Device Biologics Firm of the Year which it won in March 2009.

ApaTech’s success is founded on Actifuse, a unique silicate substituted calcium phosphate bone graft material which ApaTech manufactures and supplies globally. Actifuse scaffold mimics the body’s natural boney structure and accelerates the growth of high quality bone.

The scientific foundations and ground breaking research behind Actifuse is one of the major factors that separates ApaTech from competitors in the bone grafting market, and from alternative surgical approaches – both old and new. It also underpins the transformational sales growth of the organisation. Simon Cartmell, Chief Executive Officer of ApaTech commented: “Winning awards such as this is always a great testament to the company’s success. One of our core values is ambition andwe’ve now completed a new $13m production facility which will enable us to meet $300m of sales annually, which shows where our ambition lies, so hopefully we will continue to be an ‘ever-present’ in the Deloitte Fast 50 awards for some time to come.”

Further Information: ApaTech +44 20 8731 4640 Simon Cartmell, CEO simon.cartmell@apatech.com www.apatech.com

Waughton +44 20 7796 9999 Robin Hepburn rhepburn@waughton.com www.waughton.com

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES